Company: LRHC
Filing Date: 2025-09-19
Form Type: PRE 14C
Source: 0001213900-25-089617
Chunk: 6

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-19
Form: PRE 14C
Chunk 6
---
to register up to 100,000,000 shares of Common Stock issuable pursuant to the Existing Facility Agreement. Such registration statement,
as amended, was declared effective by the SEC on August 22, 2025.

On
September 18, 2025 (“Amendment Date”), the Company and the Investor entered into an Amended and Restated Equity Purchase Facility
Agreement (“Amended Facility Agreement”), pursuant to which the parties agreed to increase the Commitment Amount under the
Facility from $150 million to $1.0 billion in shares of Common Stock. The Amended Facility Agreement amends and restates the Existing
Facility Agreement in its entirety. Except for the increase of the Commitment Amount, all material terms and conditions of the Amended
Facility Agreement are substantially the same as those provided in the Existing Facility Agreement. In connection with the Amended Facility
Agreement, on the Amendment Date, the Company also entered into an amended and restated registration rights agreement with the Investor
with respect to the resale of the shares of Common Stock issuable under the Amended Facility Agreement (the “Amended RRA”).
The Amended RRA amends and restates the Existing RRA.

Pursuant to the Amended Facility
Agreement, the Company is required to provide each stockholder entitled to vote at a meeting of stockholders of the Company (the “Stockholder
Meeting”), which shall be promptly called and held not later than sixty (60) days after the Amendment Date (the “Stockholder
Meeting Deadline”), a proxy statement in a form reasonably acceptable to the Investor and counsel, at the expense of the Company
to solicit each of the Company’s stockholders’ affirmative vote at the Stockholder Meeting for approval of the proposal (“Stockholder
Proposal”) to authorize the issuance of all of the shares of Common Stock issuable under the Facility (in excess of the $150 million
in shares of Common Stock that were previously approved by the Majority Stockholders on August 6, 2025) in compliance with the rules and
regulations of the Nasdaq Capital Market (such affirmative approval being referred to herein as the “Stockholder Approval”,
and the date such Stockholder Approval is obtained, the “Stockholder Approval Date”), and the Company is required to use its
reasonable best efforts to solicit its stockholders’ approval of such proposal and to cause the board of directors of the Company
to recommend to the stockholders that they approve such proposal. Notwithstanding the